Levin; Jeremy Ian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Levin; Jeremy Ian.The latest application filed is for "biaryl sulfonamides and methods for using same".

Company Profile

0.9.13

Levin; Jeremy Ian - New City NY
Levin, Jeremy Ian - New York NY
Levin, Jeremy Ian - Nanuet NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Biaryl Sulfonamides and Methods for Using Same App 20100137298 - Levin; Jeremy Ian ; et al.	2010-06-03
Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof App 20100029657 - Levin; Jeremy Ian ; et al.	2010-02-04
Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors Grant 7,485,667 - Levin , et al. February 3, 2	2009-02-03
Biaryl sulfonamides and methods for using same Grant 7,420,001 - Levin , et al. September 2, 2	2008-09-02
Sulfamoyl-containing Derivatives And Uses Thereof App 20080096903 - Chen; Jianxin ; et al.	2008-04-24
Dihydropyrazolo[1,5-A]pyrimidine and dihydroimidazo[1,5-A]pyrimidine derivatives and methods of use thereof App 20070219183 - Levin; Jeremy Ian ; et al.	2007-09-20
Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors App 20070155834 - Levin; Jeremy Ian ; et al.	2007-07-05
Acetylenic aryl sulfonate hydroxamic acid TACE and matrix metalloproteinase inhibitors Grant 7,199,155 - Levin , et al. April 3, 2	2007-04-03
Biaryl sulfonamides and methods for using same App 20050143422 - Levin, Jeremy Ian ; et al.	2005-06-30
Crystalline TNF-.alpha.-converting enzyme and uses thereof Grant 6,842,704 - Black , et al. January 11, 2	2005-01-11
Crystalline TNF-alpha-converting enzyme and uses thereof App 20040265983 - Black, Roy A. ; et al.	2004-12-30
Acetylenic aryl sulfonate hydroxamic acid TACE and matrix metalloproteinase inhibitors App 20040127524 - Levin, Jeremy Ian ; et al.	2004-07-01
2,3,4,5-tetrahydro-1H-(1,4)benzodiazepine-3-hydroxamic acids Grant 6,544,984 - Albright , et al. April 8, 2	2003-04-08
Crystalline TNF-alpha-converting enzyme and uses thereof App 20030004651 - Black, Roy A. ; et al.	2003-01-02
N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors Grant 6,441,023 - Venkatesan , et al. August 27, 2	2002-08-27
Crystalline Tnf-alpha-converting Enzyne And Uses Thereof App 20020081692 - BLACK, ROY A. ; et al.	2002-06-27
N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors App 20020032186 - Venkatesan, Aranapakam Mudumbai ; et al.	2002-03-14
N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors App 20020006922 - Venkatesan, Aranapakam Mudumbai ; et al.	2002-01-17
Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors App 20010051614 - Levin, Jeremy Ian ; et al.	2001-12-13
N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors Grant 6,197,791 - Venkatesan , et al. March 6, 2	2001-03-06
Preparation and use of .beta.-sulfonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors Grant 5,977,408 - Levin , et al. November 2, 1	1999-11-02
Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors Grant 5,929,097 - Levin , et al. July 27, 1	1999-07-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.